Citius Oncology, Inc. CTOR Accrued liabilities
Accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s accrued liabilities?
- Citius Oncology, Inc. (CTOR) reported accrued liabilities of $19.54M in Q1 2026.
- How has Citius Oncology, Inc.'s accrued liabilities changed year-over-year?
- Citius Oncology, Inc.'s accrued liabilities increased by 683.6% year-over-year, from $2.49M to $19.54M.
- What does accrued liabilities mean?
- Reflects the net change in expenses that have been incurred but not yet invoiced or paid by the reporting date. This metric helps track short-term operational obligations and the timing of cash outflows for accrued services or personnel costs.